(Press-News.org)
Researchers at the Max Delbrück Center show that two related enzymes, MNK1 and MNK2, act on the brain to regulate different behaviors. Their findings, published in “Molecular Psychiatry,” could help guide development of more precise therapies for neurological disorders.
Structurally, they look similar: MNK1 and MNK2 belong to the same enzyme family and are best known for regulating how cells make proteins. Their starring role in such a crucial cellular function has cast them into the spotlight as potential drug targets to treat nervous system disorders and chronic pain. But would it matter whether a drug targets only one of them?
In a study published in “Molecular Psychiatry,” researchers led by Rosalba Olga Proce, a doctoral student in the Molecular and Cellular Basis of Behavior lab led by Dr. Hanna Hörnberg at the Max Delbrück Center, set out to determine whether the two enzymes – also called kinases – perform distinct functions in the brain. The team found clear differences. Mice lacking MNK1 showed less interest in newly introduced objects than controls and impaired memory of objects. By contrast, mice without MNK2 appeared normal in object recognition tests but showed enhanced interest in social contacts.
“The behavioral differences we observed suggest that each kinase has a specialized function,” says Proce. “It might be preferable to target each kinase individually when designing drugs.”
Mouse behavior and molecular data
To uncover how these behavioral changes arose, the researchers used genetically engineered mice in which either the MNK1 or MNK2 gene was knocked out. They then combined behavioral testing with large-scale molecular analyses of brain tissue.
The team focused in particular on the cerebral cortex and on synapses – contact points where neurons communicate. Using proteomics, transcriptomics, and phosphoproteomics, they compared protein levels, gene expression, and protein phosphorylation patterns between the two types of mice.
Mice lacking MNK1 had an abundance of ribosomal proteins, which play a central role in transcribing messenger RNA into proteins. By contrast, in mice lacking MNK2, the expression and phosphorylation of proteins responsible for transmitting messages in synapses was reduced.
Notably, the researchers found that the molecular differences between the two kinases were far more pronounced in synapses than in whole-brain samples.
“We were surprised to see these differences,” says Hörnberg. “This suggest that the kinases may have different functions in the cell body compared to synapses.”
Toward more selective therapies
Instead of broadly inhibiting both kinases, future therapies might selectively target one kinase or the other to achieve more specific effects, Hörnberg adds.
She and her colleagues now aim to identify other molecules with which MNK1 and MNK2 interact. They also plan to study in greater detail, how these kinases regulate translation of messenger RNA into proteins during synaptic plasticity – the strengthening or weakening of connections between neurons over time. Synaptic plasticity is the fundamental mechanism underlying learning and memory – enabling the brain to rewire itself based on experience.
By clarifying how protein synthesis is fine-tuned at synapses, the team hopes to lay the groundwork for more precise interventions in neurological and psychiatric disorders.
Max Delbrück Center
The Max Delbrück Center for Molecular Medicine in the Helmholtz Association lays the foundation for the medicine of tomorrow through our discoveries of today. At locations in Berlin-Buch, Berlin-Mitte, Heidelberg, and Mannheim, interdisciplinary teams investigate the complexity of disease at the systems level – from molecules and cells to organs and entire organisms. Together with academic, clinical, and industry partners, and as part of global networks, we turn biological insights into innovations for early detection, personalized therapies, and disease prevention. Founded in 1992, the Max Delbrück Center is home to a vibrant, international research community of around 1,800 people from over 70 countries. We are 90 percent funded by the German federal government and 10 percent by the state of Berlin.
END
SAN ANTONIO — February 19, 2026 — New research by Southwest Research Institute (SwRI) and the National Science Foundation’s National Center for Atmospheric Research (NSF-NCAR) has developed a new tool providing a first step toward the ability to forecast space weather weeks in advance, instead of just hours. This advance warning could allow agencies and industries to mitigate impacts to GPS, power grids, astronaut safety and more.
“Understanding where and when large, flare-producing active regions ...
(Santa Barbara, Calif.) — Ozempic has been making headlines for its remarkable success in treating obesity and diabetes. Yet it is just one in a rapidly growing class of drugs called peptide therapeutics that sits between small molecules (like aspirin) and biologics (like antibodies).
A UC Santa Barbara research team has developed a technique for efficiently synthesizing non-natural amino acids and applying them to peptide construction. They hope that the methodology, published in the Journal of the American Chemical Society, will significantly advance peptide research, giving scientists greater access to amino acids beyond the 22 found in nature.
“The ...
When you finish a run, your muscles may feel like they did all the work. But researchers at The Jackson Laboratory (JAX) and the University of Pennsylvania (UPenn) have discovered that what happens in your brain after a run may determine whether you gain endurance over time.
Specialized neurons in the brain’s hypothalamus spring into action after a bout of exercise, the team reported in Neuron. Without the activity of these neurons, mice fail to show endurance gains, no matter how hard they sprint on a treadmill. And when the researchers artificially activated the neurons ...
Munich, Germany – 19 February 2026: With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic valve implantation in a study presented today at the EAPCI Summit 2026.1 The summit is a new event organised by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), an association of the European Society of Cardiology (ESC).
Transcatheter aortic valve implantation (TAVI) is a minimally ...
In a 2023 paper on hypoxia and glucose metabolism, our lab showed how organisms rewire their metabolism to adapt to low oxygen levels—such as those found at high altitudes. One of the most striking observations from that work was a dramatic drop in circulating blood sugar.
That study focused on mice exposed to hypoxia. Looking at epidemiological data from the United States, people living at even modest elevations show the same pattern: lower blood glucose, better glucose tolerance, reduced diabetes risk.
It ...
SAN FRANCISCO—February 19, 2026—Scientists have long known that people living at high altitudes, where oxygen levels are low, have lower rates of diabetes than people living closer to sea level. But the mechanism of this protection has remained a mystery.
Now, researchers at Gladstone Institutes have explained the roots of the phenomenon, discovering that red blood cells act as glucose sponges in low-oxygen conditions like those found on the world’s highest mountaintops.
In a new study in the journal Cell Metabolism, the team showed how red blood cells can shift their metabolism to soak up sugar from the bloodstream. At high altitude, this adaptation fuels the cells’ ...
Researchers at Columbia Engineering have developed a new gel electrolyte that both improves the lifetime and safety of anode-free lithium batteries, an emerging battery architecture that could dramatically boost energy density while simplifying manufacturing. Although such design promises higher energy density and lower cost, the approach has long been plagued by short battery life and safety concerns caused by unstable lithium plating and parasitic reactions at the electrode-electrolyte interface.
The Columbia team, led by Yuan Yang, associate professor of applied physics and applied mathematics ...
A plume of upper-atmospheric lithium pollution observed in February 2025 has been attributed to the re-entry of a specific rocket stage. The results, published in Communications Earth & Environment, are the first known direct detection of upper-atmospheric pollution from space debris re-entry.
Defunct satellites and expended rocket stages are designed to break up during their atmospheric re-entry. Previous research has focused on the risks of debris reaching the ground, but little is known about the effects that disintegrating space debris might have on the mesosphere (between approximately ...
In a Phase 3 randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors led to lower symptom burden, better cognitive outcomes, and better day to day function when compared with whole brain radiation
Researchers from Mass General Brigham Cancer Institute have found that using a form of radiation therapy that targets individual tumors rather than whole brain radiation is more optimal for patients with tumors that have spread to the brain (called brain metastases), even if a larger number of tumors are present. The finding could help improve quality of life and cognitive function for many patients diagnosed with brain metastases each ...
About The Study: This nationwide study demonstrated that adolescents and young adults with prior cervical high-grade squamous intraepithelial lesion (HSIL) faced increased cardiovascular disease risk and mortality compared with matched controls. These findings warrant further research. Meanwhile, they support heightened clinical awareness regarding cardiovascular risk evaluation and prevention in women with prior HSIL.
Corresponding Author: To contact the corresponding author, Laila Hubbert, MD, PhD, email laila.hubbert@liu.se.
To access ...
